Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility and Usability of Intrinsic Capacity Monitoring With Eforto and Its Predictive Value for Health Outcomes in Older Community-dwelling Persons

NCT05368337 is registered in ClinicalTrials.gov with Vrije Universiteit Brussel as lead sponsor.

NCT NCT05368337
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05368337 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility and Usability of Intrinsic Capacity Monitoring With Eforto and Its Predictive Value for Health Outcomes in Older Community-dwelling Persons
Lead sponsor
Vrije Universiteit Brussel
Phase
Observational
Overall status
Unknown status
Start date
May 30, 2022
Completion date
December 31, 2023
Enrollment
160 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

frailty